Market open
ProPhase Labs/$PRPH
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About ProPhase Labs
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
Ticker
$PRPH
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
113
Website
ProPhase Labs Metrics
BasicAdvanced
$12M
-
-$1.51
-0.10
-
Price and volume
Market cap
$12M
Beta
-0.1
52-week high
$7.48
52-week low
$0.22
Average daily volume
18M
Financial strength
Current ratio
1.472
Quick ratio
1.12
Long term debt to equity
57.85
Total debt to equity
77.622
Interest coverage (TTM)
-12.60%
Management effectiveness
Return on assets (TTM)
-24.12%
Return on equity (TTM)
-58.71%
Valuation
Price to revenue (TTM)
0.709
Price to book
0.24
Price to tangible book (TTM)
0.41
Price to free cash flow (TTM)
-0.543
Growth
Revenue change (TTM)
-79.66%
Earnings per share change (TTM)
141.44%
3-year revenue growth (CAGR)
-31.13%
3-year earnings per share growth (CAGR)
58.93%
What the Analysts think about ProPhase Labs
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for ProPhase Labs stock.
ProPhase Labs Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ProPhase Labs Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
ProPhase Labs News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for ProPhase Labs stock?
ProPhase Labs (PRPH) has a market cap of $12M as of February 26, 2025.
What is the P/E ratio for ProPhase Labs stock?
The price to earnings (P/E) ratio for ProPhase Labs (PRPH) stock is 0 as of February 26, 2025.
Does ProPhase Labs stock pay dividends?
No, ProPhase Labs (PRPH) stock does not pay dividends to its shareholders as of February 26, 2025.
When is the next ProPhase Labs dividend payment date?
ProPhase Labs (PRPH) stock does not pay dividends to its shareholders.
What is the beta indicator for ProPhase Labs?
ProPhase Labs (PRPH) has a beta rating of -0.1. This means that it has an inverse relation to market volatility.